VIMTA Labs Limited – Stock Recommendation ( Buy or Sell ) | Best Stocks to Buy in July 2022

Vimta Labs is among the largest contract research and testing company and has a well furbished laboratory that is round 4 lakh square feet large. This company caters to the requirements for industries like agrochemicals, medical devices, pharmaceuticals, consumer goods, etc. Their labs are situated in 9 different locations, with the largest in Hyderabad.

About 60% of the company’s revenue is derived from the Pharma Contract Research and the rest from other divisions. Our reports have speculated that the Global Preclinic CRO market is expected to register a CAGR of 8% till 2028. Also, the E & E business vertical is expected to develop  at better rates. SMIFS recommends its users to buy stocks of this company for a time period of 12 months.